GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mediera Corp (ROCO:5398) » Definitions » Cyclically Adjusted Price-to-FCF

Mediera (ROCO:5398) Cyclically Adjusted Price-to-FCF : 78.10 (As of Jun. 02, 2025)


View and export this data going back to 1999. Start your Free Trial

What is Mediera Cyclically Adjusted Price-to-FCF?

As of today (2025-06-02), Mediera's current share price is NT$22.65. Mediera's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was NT$0.29. Mediera's Cyclically Adjusted Price-to-FCF for today is 78.10.

The historical rank and industry rank for Mediera's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

ROCO:5398' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 55   Med: 96.39   Max: 113.06
Current: 73.93

During the past years, Mediera's highest Cyclically Adjusted Price-to-FCF was 113.06. The lowest was 55.00. And the median was 96.39.

ROCO:5398's Cyclically Adjusted Price-to-FCF is ranked worse than
78.22% of 326 companies
in the Drug Manufacturers industry
Industry Median: 31.13 vs ROCO:5398: 73.93

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Mediera's adjusted free cash flow per share data for the three months ended in Mar. 2025 was NT$0.354. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is NT$0.29 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Mediera Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Mediera's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mediera Cyclically Adjusted Price-to-FCF Chart

Mediera Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 107.96

Mediera Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 107.96 57.14

Competitive Comparison of Mediera's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Mediera's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mediera's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mediera's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Mediera's Cyclically Adjusted Price-to-FCF falls into.


;
;

Mediera Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Mediera's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=22.65/0.29
=78.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mediera's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Mediera's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.354/134.9266*134.9266
=0.354

Current CPI (Mar. 2025) = 134.9266.

Mediera Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.093 100.684 -0.125
201509 0.106 100.392 0.142
201512 -0.229 99.792 -0.310
201603 1.881 100.470 2.526
201606 -0.385 101.688 -0.511
201609 -0.309 101.861 -0.409
201612 -1.616 101.863 -2.141
201703 0.505 102.862 0.662
201706 0.961 103.349 1.255
201709 0.158 104.136 0.205
201712 0.189 104.011 0.245
201803 -0.027 105.290 -0.035
201806 -0.923 106.317 -1.171
201809 -0.289 106.507 -0.366
201812 0.599 105.998 0.762
201903 0.715 107.251 0.900
201906 -0.512 108.070 -0.639
201909 -0.464 108.329 -0.578
201912 0.537 108.420 0.668
202003 -0.163 108.902 -0.202
202006 -0.123 108.767 -0.153
202009 0.263 109.815 0.323
202012 -0.107 109.897 -0.131
202103 -0.178 111.754 -0.215
202106 0.242 114.631 0.285
202109 1.201 115.734 1.400
202112 0.820 117.630 0.941
202203 0.019 121.301 0.021
202206 -0.477 125.017 -0.515
202209 -0.374 125.227 -0.403
202212 0.049 125.222 0.053
202303 -0.046 127.348 -0.049
202306 0.308 128.729 0.323
202309 0.028 129.860 0.029
202312 0.286 129.419 0.298
202403 -0.008 131.776 -0.008
202406 -0.773 132.554 -0.787
202409 -0.088 133.029 -0.089
202412 0.387 133.157 0.392
202503 0.354 134.927 0.354

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mediera  (ROCO:5398) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Mediera Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Mediera's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Mediera Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 239 Datong Road, Section 1, 16th Floor, Xizhi District, New Taipei, TWN
Mediera Corp is engaged in domestic research and development, production and manufacturing of various power supply components, and launched its own brand. MEDIERA is also committed to the production of customized products and OEM. It has been more active in the transformation and layout of the development of medical biotechnology. For example, medicines, healthy foods, and medical equipment that greatly help human health have become the focus of development in recent years. In addition, combined with the scientific and technological research and development capabilities of the Electronics Division, advanced The application of electronic micro-control patented technology in electronic medical equipment that can help patients improve their quality of life is a major breakthrough for company.

Mediera Headlines

No Headlines